TAG:
ameripath
“June 19, 2000 Intelligence: Late Breaking Lab News”
At DIANON Systems, Inc., recent growth in revenues and profits may cost the anatomic pathology company its independence. In recent weeks there’s been widespread speculation that DIANON may be involved in some type of acquisition or merger negotiations. At various times, each of the…
Columbia/HCA, AmeriPath, Epitope, STC Technologies, Quest Diagnostics
COLUMBIA/HCA GETS NEW NAME; ACQUIRES FOUR LONDON HOSPITALS NOW THAT IT HAS A SETTLEMENT with the federal government on civil claims of Medicare fraud, expect a rapid cascade of changes at Columbia/HCA Healthcare Corporation, the nation’s largest for-profit hospital company…
2000’s Movers & Shakers Represent Strong Leaders
CEO SUMMARY: Its time again for THE DARK REPORT to make its yearly selection of the lab industry’s Movers & Shakers. Individuals chosen for 2000 represent a cross section of laboratory companies. Their successes demonstrate that leadership and vision continue to make a difference, d…
AmeriPath Pursues Ambitious Strategy Of Rapid Expansion
CEO SUMMARY: As the pathology profession’s only publicly-traded physician practice management company, AmeriPath is the spear point of far-reaching changes now transforming pathology. With an annual revenue run rate of $270 million and an ample war chest of growth capital, AmeriPath int…
Park City Solutions, DIANON, IMPATH American Med Labs, Cytyc, TriPath Imaging
PARK CITY SOLUTIONS AND AMERICAN MEDICAL LABS CREATE STRATEGIC PACT TWO COMPANIES FINANCED by GTCR Golder Rauner, LLC, the private equity firm based in Chicago, announced a strategic relationship. Park City Solutions, Inc. of Park City, Utah and Ame…
Single-Specialty Path PPMs Posting Strong Growth, Profits
CEO SUMMARY: Although the financial travails of the physician practice management (PPM) industry are widely known, there is little recognition that a number of single-specialty PPMs are doing well. This is true of pathology, where at least six pathology-based PPMs still remain in business…
New Blood Entering the Lab Industry
SURPRISE! THERE’S A QUIET MANAGEMENT REVOLUTION UNDER WAY in both the clinical laboratory industry and pathology profession. During the past few years, a steady flow of new-thinking Presidents and CEOs have taken control of laboratories, pathology group practices, and vendor companies. From CEO Ke…
Pathology Profession Facing New Directions
CEO SUMMARY: Big changes ahead during the next decade. Among the predictions: the number of two and three-pathologist group practices will radically diminish; pathology centers of excellence will achieve new market dominance; and…ever more intense competition for anatomic pathology spec…
Individual Pathologist “Branding” Promoted by National Firms
IN THE EFFORT TO GAIN COMPETITIVE market advantage, IMPATH, Inc. of New York City publicized the recent signing of an exclusive partnership agreement involving renowned pathologist Juan Rosai, M.D., also of New York City. Dr. Rosai has a world-wide reputation for his books, book cha…
“January 3, 2000 Intelligence: Late Breaking Lab News”
Recent developments prove that the feds are serious about healthcare fraud and abuse! Sentencing was announced last month for the two Columbia/HCA hospital executives convicted last July 2 on charges of conspiring to defraud Medicare and other government healthcare programs. On Dece…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.